Onstryv (safinamide)

pCPA File Number: 21195
Negotiation Status:
Concluded with an LOI
Indication(s):
Parkinson's disease
Sponsor/Manufacturer:
Valeo Pharma Inc.
CDA-AMC Project Number:
SR0617
pCPA Engagement Letter Issued:
Negotiation Process Concluded: